What is the role of statins in the prevention of recurrent posterior cerebral artery (PCA) stroke?

Updated: Jul 30, 2018
  • Author: Erek K Helseth, MD; Chief Editor: Helmi L Lutsep, MD  more...
  • Print

Numerous statins (eg, lovastatin, simvastatin, pravastatin, atorvastatin) are available. All inhibit the enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme in the anabolism of cholesterol. These drugs are effective in reducing levels of low-density lipoprotein (LDL) cholesterol but have less effect on high-density lipoprotein (HDL) cholesterol and triglycerides.

The statins may have other, pleiotropic effects in stroke prevention, such as plaque stabilization, reduction of free radical formation, and anti-inflammatory, immunomodulatory, and antiplatelet effects. Additionally, prestroke use of statins may be associated with smaller infarct or better outcomes. Large vessel atherosclerosis may undergo regression in patients treated with statin therapy.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!